skip to Global Navigation Bar skip to main content


homeHome > In-License > Core-Competency

 Core-Competency

Strong Sales Team

  • › 719 Medical Representatives Covering the Entire Korean Market
  • › A Total of 132,000 Calls are Implementing Every Month
  • › 252 Medical Representatives Covering 1,000 Hospitals
  • › 467 Medical Representatives Covering 15,000 Clinics
  • › Close Relationship with Korean Academic Societies

Developing Qualified Marketing Representatives

  • › Periodic and Intensive Training Regimen: 60 Days Per a Year for All Employees
  • › Qualified Training System on Science-Related Material and Product Information by Medical Doctors, Professors and Product Managers
  • › Unique Training Subjects: Consulting for Clinic & Pharmacy Management

Past and Current Administrated Clinical Trials

Pipeline
Class Therapeutic Class Products Originator Experience Stage
Chemical Cardio/Metabolism OLMETEC Sankyo PIII (BS), PIV M
DIABEX Merck PIV M
GLURIAD Merck PIV M
DYNACIRC Novartis PIV M
Gastrointestinal ALBIS Daewoong PII M
ALBIS Daewoong PIV M
BEARGEL Daewoong PII, PIII M
GASMOTIN Daewoong PIV M
GASMOTIN Daewoong PI M
Anticancer LUPHERE3.75mg Daewoong PIV M
Respiratory ERDOS IDMA PIII M
Anti-fungal FLUNAZOLE Daewoong PIV M
Anticancer LUPHERE11.25mg Daewoong Nonclinical, PIII PIII
CNS DWJ204 Daewoong Nonclinical, PI PI
Biological

Wound Healing

EASYEFSpray Daewoong Nonclinical, PI, PII M
NEPIDERMIN Ointment Daewoong Nonclinical, PI, PII, PIII M
Blood EPOSIS Daewoong Nonclinical, PIII M
Hormone CARETROPIN Daewoong Nonclinical, PIII NDA
Anticancer OncolyticAdenovirus Daewoong Nonclinical, PI PI
Generics Cardio/Metabolism CLOPIDOGREL Daewoong PI M
Anti-fungal FLUNAZOLE Daewoong PI M
chemical cardio/metabolism DWP05195 Daewoong Nonclinical, PI PI
eye DWP10292 Daewoong Nonclinical, PI PI
CNS GLIATILIN ITALPHARMACO PIV M
HBV Infection MIV-210 Medivir PII PII

Regulatory Capability from NCE to Biologics

  • NDA Process
    • - Highly Experienced Completing NDA Process by Conducting Bridging Studies for Licensed Best-Selling Products
    • - The Only Korean Company to Have Biologics Products Approved by the Korean Government
    • - Daewoong Waives Bridge Studies to Specific Therapeutic Categories
  • Regular Managing
    • - Extensive Experience Managing Over 400 Product Registrations
    • - Covering All Regulatory Issues Including :
      • IND / NDA / ANDA Submission and Approval
      • DMF & GMP Inspection
      • Safety & Efficacy Documentation
      • CMC Documentation
      • Drug Revaluation
      • Post Approval Modification
      • Clinical Trials Inspection